Launch recap: SpaceX rocket launch from Cape Canaveral early Monday in Florida
Original story: For those up late, SpaceX plans to launch a Falcon 9 rocket on a Starlink mission overnight from Cape Canaveral.
The launch is now set for no earlier than 3:57 a.m. Monday August 4 from Launch Complex 40 at Cape Canaveral Space Force Station. Should SpaceX need more time to make the launch, the window runs until 4:11 a.m.
The mission, known as Starlink 10-30, is the next batch of SpaceX's Starlink internet satellites. With this payload being in the group 10 of the satellite constellation, the launch will be headed northeast after liftoff.
There will be no Space Coast sonic boom, as the rocket's booster will land on the Just Read the Instructions drone ship stationed out in the Atlantic Ocean just over eight minutes after liftoff.
When is the next Florida launch? Is there a launch today? Upcoming NASA, SpaceX, ULA rocket launch schedule at Cape Canaveral
Countdown Timer
SpaceX Falcon 9 booster lands
Update 4:06 a.m.: The Falcon 9 first-stage booster just landed aboard SpaceX's drone ship Just Read the Instructions out on the Atlantic Ocean, completing its 21st mission.
SpaceX Liftoff!
Update 3:57 a.m.: SpaceX has just launched the Falcon 9 rocket carrying 28 Starlink satellites from Cape Canaveral SLC-40!
SpaceX launch webcast begins
Update 3:52 a.m.: SpaceX's launch webcast hosted on X (formerly Twitter) is now posted above, right below the countdown clock.
Liftoff is scheduled in five minutes from Cape Canaveral Space Force Station.
We are 10 minutes from tonight's SpaceX Falcon 9 rocket launch!
Update 3:47 a.m.: T-10 minutes! Head outside if you plan on catching this launch! If you have clear skies, it will be hard to miss the bright rocket rising into the night sky.
Simply look towards the direction South of Kennedy Space Center from your direction.
SpaceX launch countdown timeline
Update 3:37 a.m.: T-20 minutes until this morning's launch.
Here's a behind-the-scenes rundown of SpaceX's countdown timeline. T-minus:
38 minutes: SpaceX launch director verifies 'go' for propellant load.
35 minutes: Rocket-grade kerosene and first-stage liquid oxygen loading begins.
16 minutes: Second-stage liquid oxygen loading begins.
7 minutes: Falcon 9 begins engine chill prior to launch.
1 minute: Command flight computer begins final prelaunch checks; propellant tank pressurization to flight pressure begins.
45 seconds: SpaceX launch director verifies 'go' for launch.
3 seconds: Engine controller commands engine ignition sequence to start.
0 seconds: Liftoff.
SpaceX Falcon 9 fueling now underway
Update 3:27 a.m.: Visual cues indicate Falcon 9 fueling procedures are now underway at Launch Complex 40, though SpaceX has yet to make an official announcement.
That means tonight's Starlink mission is now locked in to lift off at 3:57 a.m. without any countdown delays, or else the launch must be postponed.
SpaceX launch in Florida liftoff time moved
Update 3:09 a.m.: The launch has now slipped to 3:57 a.m. SpaceX has not given a reason for the delay, yet weather lingers to the north.
SpaceX Falcon 9 rocket launch in Florida booster
Update 3:00 a.m.: This first-stage, also known as the booster, is seeing its 21st flight this morning. It previously flew 14 Starlink missions, Axiom Ax-2, Euclid, Axiom Ax-3, CRS-30, SES ASTRA 1P, and NG-21.
SpaceX liftoff in Florida less than an hour
Update 2:48 a.m.: Liftoff is in less than an hour, if all continues to go well with weather. Liftoff is now at 3:44 a.m.
SpaceX launch from Cape Canaveral liftoff time
Update 2:35 a.m.: This morning's launch is still set for 3:43 a.m., however weather lingers to the northeast of the Cape.
SpaceX has until 4:11 a.m. to make this launch today. It remains to be seen if weather will clear in time.
SpaceX launch in Florida time update
Update 2:15 a.m.: SpaceX has once again pushed the launch time. Liftoff is now no earlier than 3:43 a.m.
SpaceX launch time update
Update 1:57 a.m.: With weather still over Cape Canaveral, SpaceX has pushed the liftoff time to 3:19 a.m.
Tropical weather could form off Florida Coast
Update 1:55 a.m.: While it does not impact this morning's launch, weather is shaping up that is worth noting.
Tropical Storm Dexter has formed out in the Atlantic Ocean yet poses no threat to Florida. The system is predicted to move away from the U.S. and pass north of Bermuda.
The National Hurricane Center in Miami, Florida is watching two other possible areas of tropical weather development in the Atlantic Ocean.
Disturbance number three (in yellow) has a 20% chance of development this coming week. It is predicted to drift west or northwest.
SpaceX launch from Florida new liftoff time
Update 1:33 a.m.: SpaceX has updated that liftoff is now no earlier than 3 a.m.
SpaceX has until 4:11 a.m. to make this launch window.
SpaceX launch from Cape Canaveral
Update 1:30 a.m.: This morning's SpaceX launch is still slated for 2:37 a.m.
Weather is currently moving to the northeast − the direction this mission is flying.
SpaceX launch in Florida: liftoff time moves again
Update 12:53 a.m.: SpaceX has pushed the launch to 2:37 a.m.
SpaceX launch prep underway in Brevard
Update 12:45 a.m.: Brevard County Emergency Management officials have activated the agency's launch operations support team ahead of SpaceX's upcoming Falcon 9 launch.
The launch is currently slated for 2:01 a.m. from Launch Complex 40 at Cape Canaveral Space Force Station. Should weather still be an issue, SpaceX has until 4:11 a.m. to launch this morning.
Kenndy Space Center and Cape Canaveral Space Force Station weather
Update 12:20 a.m.: Kennedy Space Center and Cape Canaveral Space Force Station are under a Phase II lightning watch.
This means all activities are paused until the weather passes.
Launch is now scheduled for 2:01 a.m.
Tonight's SpaceX drone ship
Update 12:18 a.m.: The only sound heard from this launch will be the Falcon 9's familiar roar. The rocket's first-stage booster will land out on the Just Read the Instructions drone ship in the Atlantic Ocean.
NASA SpaceX Crew-11 docks to ISS
Update 12:08 a.m.: In case you missed it, NASA's SpaceX Crew-11 docked to the International Space Station during the early hours of Saturday. The four launched to the ISS from NASA's Kennedy Space Center Pad 39A on the morning of Friday, August 1.
As Crew-10 now prepares to come home, Crew-11 settle in for at least a six-month stay. Crew-11 will be onboard the ISS for a milestone anniversary in Novemeber − 25 years of continuous crew rotations.
SpaceX launch in Florida weather update
Update 11:55 p.m.: As storms moved through the area, SpaceX pushed the launch to 1:27 a.m.
As lightning still flashes in the skies over Brevard, storms are currently moving out of the area.
Brooke Edwards is a Space Reporter for Florida Today. Contact her at bedwards@floridatoday.com or on X: @brookeofstars.
This article originally appeared on Florida Today: Launch recap: SpaceX rocket launches in Florida during overnight hours
Solve the daily Crossword
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
What To Expect From Uber's (UBER) Q2 Earnings
Ride sharing and on-demand delivery platform Uber (NYSE:UBER) will be reporting results this Wednesday before the bell. Here's what you need to know. Uber missed analysts' revenue expectations by 0.5% last quarter, reporting revenues of $11.53 billion, up 13.8% year on year. It was a mixed quarter for the company, with strong growth in its users. It reported 170 million users, up 14.1% year on year. Is Uber a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Uber's revenue to grow 16.6% year on year to $12.48 billion, in line with the 15.9% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.82 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Uber has missed Wall Street's revenue estimates three times over the last two years. Looking at Uber's peers in the consumer internet segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Fiverr delivered year-on-year revenue growth of 14.8%, beating analysts' expectations by 0.9%, and Shutterstock reported revenues up 21.3%, topping estimates by 7.5%. Fiverr traded down 11.7% following the results while Shutterstock's stock price was unchanged. Read our full analysis of Fiverr's results here and Shutterstock's results here. Investors in the consumer internet segment have had steady hands going into earnings, with share prices up 1.5% on average over the last month. Uber is down 8% during the same time and is heading into earnings with an average analyst price target of $100.54 (compared to the current share price of $88.90). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
Bloomberg
19 minutes ago
- Bloomberg
SoftBank Builds Nvidia, TSMC Stakes Under Son's Focus on AI Gear
SoftBank Group Corp. is building up stakes in Nvidia Corp. and Taiwan Semiconductor Manufacturing Co., the latest reflection of Masayoshi Son's focus on the tools and hardware underpinning artificial intelligence. The Japanese technology investor raised its stake in Nvidia to about $3 billion by the end of March, up from $1 billion in the prior quarter, according to regulatory filings. It bought around $330 million worth of TSMC shares and $170 million in Oracle Corp., they show.
Yahoo
an hour ago
- Yahoo
Long Covid Patients Can Sign up for Remote Clinical Trial Notification, Announces CareEvolution
At-home participation in a study by Scripps Research and Schmidt Initiative for Long Covid powered by CareEvolution's MyDataHelps® platform ANN ARBOR, Mich., August 05, 2025--(BUSINESS WIRE)--Long Covid patients around the U.S. looking to participate in a clinical trial from home can sign up to be notified when an upcoming study conducted by scientists at Scripps Research and supported by the Schmidt Initiative for Long Covid (SILC) opens. Patients can sign up on the Long Covid Treatment Trial (LoCITT) website. The upcoming study, powered by the MyDataHelps platform from CareEvolution, is a fully remote clinical trial investigating the efficacy of a repurposed drug for treating Long COVID. It will enroll 1,000 Long Covid patients from across the U.S. The app-based study enables participants to enroll and participate in all trial activities without having to visit a trial clinic. "Decentralized trials broaden reach, speed timelines and yield richer real-world evidence," said Vik Kheterpal, MD, a principal at CareEvolution. "LoCITT will help advance how efficiently we can run trials as we seek treatments for complex, heterogeneous conditions like Long Covid." Long Covid, which has affected the lives of 400 million people worldwide and costs the global economy an estimated $1 trillion per year, can often cause symptoms that make mobility and travel challenging for patients who want to participate in trials. The forthcoming Scripps Research-led trial will rely on the LoCITT platform to enroll patients, distribute drug candidates and placebos, as well as collect and evaluate trial data. "For people with severe Long Covid, travel can be dangerous," said Julia Moore Vogel, senior program director at the Scripps Research Translational Institute. "LoCITT enables even patients with the most severe symptoms to join the search for answers." Moore Vogel is co-principal investigator of the study alongside Scripps Research executive vice president Eric Topol. Remote trials, which eliminate the need for patients to report to clinics, enable easier and broader participation. Conducting a Long Covid trial remotely will also allow more representative cohorts—potentially leading to more generalizable findings. "We need aggressive, rapid efforts to turn the tide on this very difficult condition for all the patients who struggle with it," said John Redd, CEO of SILC. "We're hopeful that a remote trial will help us find effective treatments more quickly." CareEvolution adapted its existing MyDataHelps decentralized clinical trial platform specifically for the LoCITT trial, with the potential for it to be used by other research efforts. The platform will allow for patients to be screened, enrolled and randomized more swiftly. Potential treatments and placebos will be mailed directly to the participant's home, along with wearable devices and other technologies to collect patient data. CareEvolution's user-friendly platform allows patients to check their eligibility, provide consent electronically and respond to baseline and ongoing surveys about their symptoms. Patients selected for the study will receive wrist devices to monitor their heart rates, activity and sleep, potentially enabling the development of digital biomarkers for Long Covid and related conditions like myalgic encephalomyelitis (ME), which can cause debilitating fatigue, and postural orthostatic tachycardia syndrome (POTS), which can cause dizziness, fatigue and a rapid heart rate upon standing up. The data from the devices will be uploaded to LoCITT. Prospective participants who are 18 years of age or older and who believe they have Long Covid can sign up at to be notified when the Scripps clinical trial opens. About CareEvolution We Connect Healthcare. MyDataHelps®, our digital clinical trials platform, accelerates healthcare innovation by empowering researchers to configure and launch studies in hours. We enable anyone, anywhere to be able to participate in research using participant centric design that integrates surveys, wearable and sensor data, EHR connectivity, and participant engagement tools to generate robust real-world longitudinal data. Trusted by over 2.5 million participants enrolled in longitudinal initiatives sponsored by health systems, academic institutions, life science companies, foundations, and public health agencies, CareEvolution advances precision health and helps close critical gaps in our collective understanding of complex conditions. For more information please visit About the Schmidt Initiative for Long Covid The Schmidt Initiative for Long Covid (SILC) advances clinical care for Long Covid patients globally. The nonprofit organization, founded in 2023 by philanthropists Eric and Wendy Schmidt, works to raise the level of Long Covid care and understanding around the world, connecting specialists and primary care providers to support patients and share knowledge virtually, in real time. For more information, visit About Scripps Research Scripps Research is an independent, nonprofit biomedical institute ranked one of the most influential in the world for its impact on innovation by Nature Index. We are advancing human health through profound discoveries that address pressing medical concerns around the globe. Our drug discovery and development division, Calibr-Skaggs, works hand-in-hand with scientists across disciplines to bring new medicines to patients as quickly and efficiently as possible, while teams at Scripps Research Translational Institute harness genomics, digital medicine and cutting-edge informatics to understand individual health and render more effective healthcare. Scripps Research also trains the next generation of leading scientists at our Skaggs Graduate School, consistently named among the top 10 US programs for chemistry and biological sciences. Learn more at View source version on Contacts CareEvolutionpr@ Swati Pandey, SILCspandey@ Anna Andersen, Scripps Researchaanders@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
